RecruitingNot applicableNCT06805630

Urine Methylation Markers in UTUC

Studying Upper tract urothelial carcinoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Duke University
Principal Investigator
Michael Abern, MD, M.D. Ph.D
Duke University
Intervention
Bladder CARE™(diagnostic_test)
Enrollment
50 target
Eligibility
18 years · All sexes
Timeline
20252026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06805630 on ClinicalTrials.gov

Other trials for Upper tract urothelial carcinoma

Additional recruiting or active studies for the same condition.

See all trials for Upper tract urothelial carcinoma

← Back to all trials